Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
Overview
General Surgery
Affiliations
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred in only 27 percent. ICC was unresectable due to advanced disease stage in 81 percent. Six patients had curative resections with two 5 year disease free survivors. Underlying liver disease was associated with ICC in 34 percent of patients.
Baimas-George M, Thompson K, Watson M, Iannitti D, Martinie J, Baker E Langenbecks Arch Surg. 2021; 406(7):2177-2200.
PMID: 33591451 DOI: 10.1007/s00423-021-02093-0.
Chen F, Zhou C, Zhang X, Zhou K, Peng Y, Yu L Exp Ther Med. 2020; 20(5):50.
PMID: 32952640 PMC: 7480127. DOI: 10.3892/etm.2020.9178.
A metastatic skull tumor from intrahepatic cholangiocarcinoma: A case report and literature review.
Wang D, He S, Chu L, Chao Q, Zhang Q, Shu H Medicine (Baltimore). 2019; 98(49):e18291.
PMID: 31804374 PMC: 6919424. DOI: 10.1097/MD.0000000000018291.
Tatsuguchi T, Gotoh K, Kobayashi S, Asukai K, Tomokuni A, Akita H Int Cancer Conf J. 2019; 7(3):93-97.
PMID: 31149523 PMC: 6498247. DOI: 10.1007/s13691-018-0327-0.
Surgery and chemotherapy for intrahepatic cholangiocarcinoma.
Morise Z, Sugioka A, Tokoro T, Tanahashi Y, Okabe Y, Kagawa T World J Hepatol. 2010; 2(2):58-64.
PMID: 21160974 PMC: 2998957. DOI: 10.4254/wjh.v2.i2.58.